Clinical Trial Update: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) [Phase 3]

View source ↗

Summary

A Phase 3 trial update for retatrutide in obesity assessing cardiovascular and kidney outcomes (TRIUMPH-Outcomes) is currently active but not recruiting, sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• Retatrutide (retatrutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | Phase 3 | Status: ACTIVE_NOT_RECRUITING